Biomx Inc Stock Performance
| PHGE Stock | USD 0.73 0.02 2.82% |
On a scale of 0 to 100, Biomx holds a performance score of 2. The firm shows a Beta (market volatility) of 1.27, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomx will likely underperform. Please check Biomx's expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Biomx's price patterns will revert.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biomx Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, Biomx exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 32.3 M |
Biomx |
Biomx Relative Risk vs. Return Landscape
If you would invest 73.00 in Biomx Inc on November 3, 2024 and sell it today you would lose (0.10) from holding Biomx Inc or give up 0.14% of portfolio value over 90 days. Biomx Inc is currently generating 0.2298% in daily expected returns and assumes 6.9026% risk (volatility on return distribution) over the 90 days horizon. In different words, 61% of stocks are less volatile than Biomx, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biomx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biomx Inc, and traders can use it to determine the average amount a Biomx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0333
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PHGE | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.9 actual daily | 61 61% of assets are less volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Biomx is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biomx by adding it to a well-diversified portfolio.
Biomx Fundamentals Growth
Biomx Stock prices reflect investors' perceptions of the future prospects and financial health of Biomx, and Biomx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biomx Stock performance.
| Return On Equity | -1.21 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | 18.84 M | ||||
| Shares Outstanding | 18.18 M | ||||
| Price To Book | 0.73 X | ||||
| Revenue | (357 K) | ||||
| EBITDA | (22.82 M) | ||||
| Cash And Equivalents | 45.74 M | ||||
| Cash Per Share | 1.53 X | ||||
| Total Debt | 15.09 M | ||||
| Debt To Equity | 0.59 % | ||||
| Book Value Per Share | 0.67 X | ||||
| Cash Flow From Operations | (21.29 M) | ||||
| Earnings Per Share | (3.26) X | ||||
| Total Asset | 25.03 M | ||||
| Retained Earnings | (162.97 M) | ||||
About Biomx Performance
By analyzing Biomx's fundamental ratios, stakeholders can gain valuable insights into Biomx's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biomx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biomx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel. Biomx operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 103 people.Things to note about Biomx Inc performance evaluation
Checking the ongoing alerts about Biomx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biomx Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biomx Inc had very high historical volatility over the last 90 days | |
| Biomx Inc has some characteristics of a very speculative penny stock | |
| Biomx Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (26.17 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biomx Inc currently holds about 45.74 M in cash with (21.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Biomx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biomx's stock is overvalued or undervalued compared to its peers.
- Examining Biomx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biomx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biomx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biomx's stock. These opinions can provide insight into Biomx's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Biomx Stock analysis
When running Biomx's price analysis, check to measure Biomx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomx is operating at the current time. Most of Biomx's value examination focuses on studying past and present price action to predict the probability of Biomx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomx's price. Additionally, you may evaluate how the addition of Biomx to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |